Sep 19, 2022 | Case studies

Product commercialization case study

A global pharma company needed pharmacovigilance expertise following a European Medicines Agency inspection which resulted in several critical findings. They required a robust pharmacovigilance system that is compliant with the requirements of the FDA, EMA, and other national health authorities.

Qinecsa implemented a fully compliant pharmacovigilance framework in line with US, Canadian, and European regulatory requirements.